Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis.

Blood Pressure Lowering Treatment Trialists' Collaboration. · 2021

Read Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis. by Blood Pressure Lowering Treatment Trialists' Collaboration. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8102467.txt.

Description

Blood Pressure Lowering Treatment Trialists' Collaboration pooled patient-level data from 48 randomized trials to test who gains from blood pressure drugs. The analysis covered 344,716 participants in total. Some had prior cardiovascular disease, many had none. Baseline pressures ranged from under 120 to over 170 mm Hg. Whether treatment helps at normal starting pressures was the open question.

Follow-up ran a median of just over four years per participant. In that span, 42,324 participants had at least one major cardiovascular event. The benefit of treatment scaled with how far pressure fell. Bigger drops in systolic pressure bought bigger risk cuts. The pattern held across the baseline pressure range. It held for people with and without past disease alike. Gains appeared even among those starting below 130 mm Hg systolic. The authors read this as a case for treating risk, not just high readings. Fixed drug plans could suit most adults.

Catalog record

CREATORBlood Pressure Lowering Treatment Trialists' Collaboration.
YEAR2021
COLLECTIONPAPERS
FORMATTXT
FILE SIZE60 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC8102467

Browse the full library · About the Tower of Babel